Inventor · disambiguated record
Jason Baum
Also filed as: BAUM JASON · BAUM JASON MICHAEL
4 granted patents·6 pending applications·25 citations·filing 2005–2017
72Inventor score
Top patents by PatentIndex Score
10 records- 0191US8476409B2Bispecific anti-IGF-1R and anti-ErbB3 antibodiesBAUM JASON·Filed 2012·Granted Jul 2, 2013·22 cites·15 claims
- 0279US9556274B2Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2013·Granted Jan 31, 2017·2 cites·10 claims
- 0373US9527914B2Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Dec 27, 2016·1 cites·6 claims
- 0461US9938346B2Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Granted Apr 10, 2018·0 cites·24 claims
- 0552US2015231219A1Dosage and administration of monospecific and bispecific anti-igr-1r and anti-erbb3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0650US2018036395A1Dosage and administration of monospecific and bispecific anti-igr-1r and anti-erbb3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0743US2017233491A1Dosage and administration of combination therapies comprising istiratumab, uses and methods of treatmentMERRIMACK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0838US2005240430A1Management system for a business enterpriseBAUM JASON·Filed 2005·Application pending·0 cites
- 0937US2017096492A1DOSAGE AND ADMINISTRATION OF ANTI-IGF-1R, ANTI-ErbB3 BISPECIFIC ANTIBODIES, USES THEREOF AND METHODS OF TREATMENT THEREWITHMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1031US2017154312A1System and a method for securely verifying employee dataWilson Joshua Luke·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →